EASD 2020: HbA1c Reduction Explains the Reduction in CV Events With GLP1 Receptor Agonists
Data from 7 trials of the drug class were reviewed.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Data from 7 trials of the drug class were reviewed.
Only registered members have full access to PracticeUpdate content.